Today’s AI Top Pick: PDD

7/7/2026 · Recently Alerted GARP screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live PDD price forecast →

Today's pick · Recently Alerted GARPPDDBUY NOW8.8 / 107/7/2026

PDD is the cleanest setup in the pool right now: it combines top-tier fundamentals with multi-timeframe forecast agreement AND it isn't stretched. Fundamentals are elite for a screen this cheap — fwdPe 6.81, PEG 0.60, profit margin 21.86%, ROE 25.52%, sales growth 11.69%, EPS Next Y 20.39%, debt/eq 0.01, and a market cap of $119B means it's liquid enough to trade in size. Fundamental_score is a full 8 and bullish_prob is 1.0. The tape confirms without begging you to chase. Near_term_bullish is 1.0 (highest tier). Every forecast horizon that matters is green: 1h fc_mid +12.52 / long +21.78; 4h fc_mid +34.86 / long +22.29; 1d fc_short +15.12, mid +21.43, long +26.19; 1wk fc_short +11.30, mid +31.72, long +16.81. Four-timeframe forecast agreement to the upside is the 'gold' setup the brief asks for, and PDD is the only fully-covered name that delivers it. Positioning is favorable — 1d pos_in_21bar_range 82.24 with only -2.46% drawdown (buying strength, not top-tick), and 1wk pos is just 22.65% meaning the weekly base is still in accumulation, not distribution. News is a non-issue: Zacks/Yahoo attention flow is neutral-to-slightly-positive with Daiwa at Hold — no guidance cuts, no legal overhang, no dilution. Compare that to the other top-fundamental names where headlines actively disqualify them: FUTU has a DOJ probe and class actions (7/3), PODD has a serious-classified FDA Omnipod recall (7/6), CRK just got a Goldman Sell with a $10 PT. PDD is clean. Why TODAY vs. waiting: the weekly is still down 20.93% from the 21-bar high but the daily and intraday have already turned — this is the exact 'weekly base + daily inflection' pattern. Waiting for a deeper pullback risks missing the mid-term 21-26% forecast move. The 4h drawdown is only 1.52% — the pullback already happened intraday and the tape is re-accelerating.

Entry zone
$81.50 - $83.50 (buy around current $82.98, add on any dip to the 20-day)
Stop loss
$77.80 (below the recent 1d consolidation floor, ~6.2% risk)
First target
$92.00 (aligned with 1d fc_short +15% and 1h fc_long +21.78%)
Longer target
$104.00 - $108.00 (1d fc_long +26% / 1wk fc_mid +31.72%)
Risks
  • China ADR / geopolitical tape risk — a single tariff or delisting headline can slice 8-12% in a session regardless of fundamentals
  • Temu-related regulatory scrutiny (de minimis exemption changes) remains an overhang on the US-facing growth story
  • Weekly still shows -20.93% drawdown from 21-bar high and pos_in_range only 22.65% — the primary weekly trend is not yet confirmed up
  • Analyst tape softened recently (Daiwa moved to Hold 7/1), recom is a lukewarm 1.93, so no near-term upgrade catalyst is priced in
  • Sales growth 11.69% is the LOWEST among China peers in the pool — deceleration risk if next print disappoints
Honorable mentions
ORCLDeep-value setup: RSI 30.05 (washed out), 1d drawdown -32.14% but forecasts are massive across the board (1d fc_short +21.57, mid +28.26, long +25.88; 1wk fc_mid +7.93). fwdPe 13.18, PEG 0.50, ROE 54.28, profit margin 25.21. Analysts screaming buy after the June -35% (headline 7/6). Slightly lower on the list only because the weekly downtrend is still severe (-35.77% dd) and the near-term bounce needs to prove itself.
ADMABest forecast magnitudes in the pool (1d fc_short +34.10, mid +62.17, long +72.47) with elite fundamentals (ROE 43.30, profit margin 32.43, PEG 0.33, fwdPe 9.51). Downgraded to #3 only because 1h/4h/1d are all at pos_in_range 100 — you'd be top-ticking today. Better as a pullback buy near $8.50.
Full ranking (30)
#SymbolVerdictScoreRead
1PDDBUY NOW8.8Only name with all four timeframes forecast-green, mid-range positioning, elite valuation (fwdPe 6.81), and clean news.
2ORCLBUY NOW8.2Deep-value oversold bounce: RSI 30, 1d forecasts +21/+28/+26%, analysts upgrading after -35% June rout.
3ADMABUY PULLBACK7.8Highest forecast magnitudes (1d long +72%) with 43% ROE, but at pos_in_range 100 on 3 timeframes — wait for pullback.
4NAGEBUY PULLBACK7.5Outsized 1d fc_short +92.6% and 242.9% targetUpside, but micro-cap ($278M) and weekly -30.83% dd — size accordingly.
5PFSIBUY NOW7.4fwdPe 5.99, PEG 0.32, 1d fc +12/+21/+15%, mid-range 45.62% — quiet, well-priced entry.
6ESTCBUY NOW7.3PEG 0.65, 4h fc_long +36%, 1wk fc_mid +62.53%; Rosenblatt Buy reiterated.
7HURNBUY NOW7.2Recom 1.00 (unanimous buy), targetUpside 84.2%, 1d fc_mid +28.96%, 1d pos 48% — solid entry, minor insider sale is noise.
8BILIBUY NOW7.0$300M buyback announced 6/24, 1d fc +20/+35/+8%, 1wk fc_mid +109%, weekly deeply oversold at pos 7.45%.
9SEBUY PULLBACK6.9Great business but 1h/4h/1d all pos_in_range >99, RSI 69.33 — wait for a pullback near $95.
10HSAIBUY PULLBACK6.744% sales growth, 1d fc +36/+22/+9%, but bullish_prob only 0.4 and weekly dd -37.79%.
11DCBOBUY NOW6.6ROE 132.85, PEG 0.45, 1d fc_mid +27.75%; small cap ($468M) but forecasts stack cleanly.
12CALXBUY PULLBACK6.41d fc +20/+24/+15% and 1d pos_in_range 100 — chase risk; buy near $36.
13SRADBUY PULLBACK6.2PEG 0.47 and 69.61% EPS growth but 1wk forecasts all negative (-9/-24/-14).
14MSFTBUY PULLBACK6.1Blue-chip base but near_term_bullish only 0.2, 1h/4h at pos 100, Xbox layoffs headline is mild negative.
15NOWBUY PULLBACK6.01d fc_mid +38.49%, defense/AI wins, but 1h/4h at pos 100 and fwdPe 21.33 leaves less margin.
16WKBUY PULLBACK5.9PE 223 is optics-ugly but PEG 0.41; 1wk fc_mid +70%, though near_term_bullish is 0.2.
17SMCIWAIT5.71d fc_mid +44% but weekly dd -42.24%, recom 3.0 (hold), short float 17.27% — needs structural repair.
18SAPWAIT5.6Solid fundamentals but analyst fair value falling and AI monetization still unproven per 7/3 note.
19GDYNBUY PULLBACK5.41wk fc_mid +154% eye-popping but SeekingAlpha downgrade (6/22) and operMargin 0.19% — speculative.
20INTRBUY PULLBACK5.3PEG 0.23 and 50% sales growth, but 1wk forecasts all negative — wait for weekly stabilization.
21MLCOBUY PULLBACK5.1PEG 0.23 and 1wk fc +20/+51/+43%, but Morgan Stanley downgrade to Equal-Weight caps upside.
22TOSTWAIT4.9RSI 69.45 and 1h fc all deeply negative (-3, -15, -14) — extended into resistance.
23AVPTWAIT4.7RSI 69.95, 1h fc -7/-16/-12, 1wk fc all negative — momentum exhaustion.
24FRSHWAIT4.6Short-term forecasts negative across 1h/4h and recom 2.07 — no near-term edge.
25UWMCWAIT4.4Debt/eq 70.65 is a red flag; price target cut 13.3% on 6/30 offset by KBW upgrade — mixed signals.
26BXWAIT4.3Expected return only 22.5%, 1h fc long -8%, targetUpside only 15.4% — better setups elsewhere.
27CEGWAIT4.1RSI 39, 1wk fc +30% but 1d dd -30% and Citi Neutral — no near-term catalyst.
28CRKAVOID3.6Goldman Sell reiterated 7/6 with $10 PT (current $14.32); Morgan Stanley also cut PT; short float 30.49%.
29FUTUAVOID3.2DOJ probe and US class actions (7/3) — regulatory landmine overrides the strong fundamentals.
30PODDAVOID3.0FDA classified Omnipod recall as Serious after injury reports (7/6) — do not step in front of that.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord